Genomic profiling has characterized many 1α,25(OH)2D3 responsive targets in normal mammary cells and in breast cancers providing valuable insight into the molecular actions of 1α,25(OH)2D3 and the VDR in regulation of cell cycle, apoptosis and differentiation. This evidence concerns the gene VDR and breast cancer.